Cargando…

Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States

AIMS: With increased liberalization of cannabis policies in North America, there is growing interest in the use of cannabis to manage pain instead of opioids. The objectives of the study were to: 1) examine the use of cannabis for pain relief in Canada and the United States (US) in 2018 and 2019; 2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadsworth, Elle, Hines, Lindsey A, Hammond, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614954/
https://www.ncbi.nlm.nih.gov/pubmed/35420977
http://dx.doi.org/10.1080/08897077.2022.2060431
_version_ 1783605673777430528
author Wadsworth, Elle
Hines, Lindsey A
Hammond, David
author_facet Wadsworth, Elle
Hines, Lindsey A
Hammond, David
author_sort Wadsworth, Elle
collection PubMed
description AIMS: With increased liberalization of cannabis policies in North America, there is growing interest in the use of cannabis to manage pain instead of opioids. The objectives of the study were to: 1) examine the use of cannabis for pain relief in Canada and the United States (US) in 2018 and 2019; 2) examine the association between recreational cannabis laws and changes in the use of cannabis for pain relief, instead of opioids or prescription pain medication. METHODS: Repeat cross-sectional survey data were used from Wave 1 and Wave 2 of the International Cannabis Policy Study conducted in 2018 and 2019 in Canada and the US. Respondents were recruited through commercial panels, aged 16-65, and had ever tried cannabis (N=44,119). Weighted binary logistic regression models examined the association between the legal status of recreational cannabis and cannabis use for pain relief instead of opioids or prescription pain medication (n=15,092). RESULTS: Between 14%-33% of cannabis consumers in Canada and the US reported using cannabis to manage headaches or pain. Of these consumers, 79% and 78% respondents in Canada; 80% and 83% in US illegal states; and 83% and 84% in US legal states, in 2018 and 2019, respectively, reported cannabis use for pain relief instead of opioids or prescription pain medication. There was little evidence of an association between the legal status of recreational cannabis and cannabis use for pain relief instead of opioids or prescription pain medication, among Canadian (AOR=0.98, 95% CI: 0.78, 1.22) and US respondents (AOR=1.11, 95% CI: 0.96, 1.28). CONCLUSIONS: Although substitution of cannabis for opioids or prescription pain medication is common among those who use cannabis for pain, there does not seem to be a significant difference according to cannabis legality. Future research should examine cannabis and opioid substitution using different research designs and time frames.
format Online
Article
Text
id pubmed-7614954
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-76149542023-08-14 Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States Wadsworth, Elle Hines, Lindsey A Hammond, David Subst Abus Article AIMS: With increased liberalization of cannabis policies in North America, there is growing interest in the use of cannabis to manage pain instead of opioids. The objectives of the study were to: 1) examine the use of cannabis for pain relief in Canada and the United States (US) in 2018 and 2019; 2) examine the association between recreational cannabis laws and changes in the use of cannabis for pain relief, instead of opioids or prescription pain medication. METHODS: Repeat cross-sectional survey data were used from Wave 1 and Wave 2 of the International Cannabis Policy Study conducted in 2018 and 2019 in Canada and the US. Respondents were recruited through commercial panels, aged 16-65, and had ever tried cannabis (N=44,119). Weighted binary logistic regression models examined the association between the legal status of recreational cannabis and cannabis use for pain relief instead of opioids or prescription pain medication (n=15,092). RESULTS: Between 14%-33% of cannabis consumers in Canada and the US reported using cannabis to manage headaches or pain. Of these consumers, 79% and 78% respondents in Canada; 80% and 83% in US illegal states; and 83% and 84% in US legal states, in 2018 and 2019, respectively, reported cannabis use for pain relief instead of opioids or prescription pain medication. There was little evidence of an association between the legal status of recreational cannabis and cannabis use for pain relief instead of opioids or prescription pain medication, among Canadian (AOR=0.98, 95% CI: 0.78, 1.22) and US respondents (AOR=1.11, 95% CI: 0.96, 1.28). CONCLUSIONS: Although substitution of cannabis for opioids or prescription pain medication is common among those who use cannabis for pain, there does not seem to be a significant difference according to cannabis legality. Future research should examine cannabis and opioid substitution using different research designs and time frames. 2022-01-01 /pmc/articles/PMC7614954/ /pubmed/35420977 http://dx.doi.org/10.1080/08897077.2022.2060431 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/) International license.
spellingShingle Article
Wadsworth, Elle
Hines, Lindsey A
Hammond, David
Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States
title Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States
title_full Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States
title_fullStr Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States
title_full_unstemmed Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States
title_short Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States
title_sort legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in canada and the united states
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614954/
https://www.ncbi.nlm.nih.gov/pubmed/35420977
http://dx.doi.org/10.1080/08897077.2022.2060431
work_keys_str_mv AT wadsworthelle legalstatusofrecreationalcannabisandselfreportedsubstitutionofcannabisforopioidsorprescriptionpainmedicationincanadaandtheunitedstates
AT hineslindseya legalstatusofrecreationalcannabisandselfreportedsubstitutionofcannabisforopioidsorprescriptionpainmedicationincanadaandtheunitedstates
AT hammonddavid legalstatusofrecreationalcannabisandselfreportedsubstitutionofcannabisforopioidsorprescriptionpainmedicationincanadaandtheunitedstates